Overview of vaccination trials for control of tuberculosis in cattle, wildlife and humans

Transboundary and Emerging Diseases

Volumn 60, Issue SUPPL1, 2013, Pages 136-146

  Buddle, B M ^a   Parlane, N A ^a   Wedlock, D N ^a   Heiser, A ^a  

^a AGRESEARCH GRASSLANDS   (New Zealand)

Author keywords

Cattle; Humans; Mycobacterium tuberculosis complex; Tuberculosis; Vaccine; Wildlife

Indexed keywords

BCG VACCINE; LIVE VACCINE; VACCINE;

ANIMAL; ANIMAL DISEASE; BOVINE TUBERCULOSIS; CATTLE; DEER; HUMAN; IMMUNOLOGY; MICROBIOLOGY; MUSTELIDAE; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS COMPLEX; REVIEW; SWINE; TUBERCULOSIS; VACCINATION; WILDLIFE;

CATTLE; HUMANS; MYCOBACTERIUM TUBERCULOSIS COMPLEX; TUBERCULOSIS; VACCINE; WILDLIFE;

ANIMALS; BCG VACCINE; CATTLE; DEER; HUMANS; MUSTELIDAE; MYCOBACTERIUM BOVIS; SUS SCROFA; SWINE; TUBERCULOSIS, BOVINE; VACCINATION; VACCINES, ATTENUATED;

EID: 84886857964     PISSN: 18651674     EISSN: 18651682     Source Type: Journal    
DOI: 10.1111/tbed.12092     Document Type: Review

References (78)

1. Abel, B., M. Tameris, N. Mansoor, S. Gelderbloem, J. Hughes, D. Abrahams, L. Makhethe, M. Erasmus, M. de Kock, L. van der Merwe, A. Hawkridge, A. Veldsman, M. Hatherill, G. Schirru, M. G. Pau, J. Hendriks, G. J. Weverling, J. Goudsmit, D. Sizemore, J. B. McClain, M. Goetz, J. Gearhart, H. Mahomed, G. D. Hussey, J. C. Sadoff, and W. A. Hanekom, 2010: The novel tuberculosis vaccine, AERAS-402, induces robust and polyfunctional CD4+ and CD8+ T cells in adults. Am. J. Respir. Crit. Care Med. 181, 1407-1417.
2. Aldwell, F. E., D. Keen, N. Parlane, M. A. Skinner, G. W. de Lisle, and B. M. Buddle, 2003: Oral vaccination with Mycobacterium bovis BCG in a lipid formulation induces resistance to pulmonary tuberculosis in possums. Vaccine 22, 70-76.
3. Ameni, G. G., H. M. Vordermeier, A. A. Aseffa, D. B. Young, and R. G. Hewinson, 2010: Field evaluation of the efficacy of Mycobacterium bovis bacillus Calmette-Guérin against bovine tuberculosis in neonatal calves. Clin. Vaccine Immunol. 17, 1533-1538.
4. Aznar, I., G. McGrath, D. Murphy, L. A. L. Corner, E. Gormley, K. Frankena, S. J. More, W. Martin, J. O'Keeffe, and M. C. M. De Jong, 2011: Trial design to estimate the effect of vaccination on tuberculosis incidence in badgers. Vet. Microbiol. 151, 104-111.
5. Bertholet, S., G. C. Ireton, D. J. Ordway, H. P. Windish, S. O. Pine, M. Kahn, T. Phan, I. M. Orme, T. S. Vedvick, S. L. Baldwin, R. N. Coler, and S. G. Reed, 2010: A defined tuberculosis vaccine candidate boosts BCG and protects against multidrug-resistant Mycobacterium tuberculosis. Sci. Transl. Med. 2, 53ra74.
6. Buddle, B. M., G. W. de Lisle, A. Pfeffer, and F. E. Aldwell, 1995: Immunological responses and protection against Mycobacterium bovis in calves vaccinated with a low dose of BCG. Vaccine 13, 1123-1130.
7. Buddle, B. M., B. J. Wards, F. E. Aldwell, D. M. Collins, and G. W. de Lisle, 2002: Influence of sensitisation to environmental mycobacteria on subsequent vaccination against bovine tuberculosis. Vaccine 20, 1126-1133.
8. Buddle, B. M., D. N. Wedlock, N. A. Parlane, L. A. L. Corner, G. W. de Lisle, and M. A. Skinner, 2003: Revaccination of neonatal calves with Mycobacterium bovis BCG reduced the level of protection against tuberculosis induced by a single vaccination. Infect. Immun. 71, 6411-6419.
9. Buddle, B. M., F. E. Aldwell, M. A. Skinner, G. W. Lisle, M. Denis, H. M. Vordermeier, R. G. Hewinson, and D. N. Wedlock, 2005: Effect of oral vaccination of cattle with lipid-formulated BCG on immune responses and protection against bovine tuberculosis. Vaccine 23, 3581-3589.
10. Buddle, B. M., F. E. Aldwell, D. L. Keen, N. A. Parlane, K. L. Hamel, and G. W. de Lisle, 2006: Oral vaccination of brushtail possums with BCG: investigation into factors that influence vaccine efficacy and determination of duration of immunity. N.Z. Vet. J. 54, 224-230.
11. Buddle, B. M., T. Wilson, F. E. Aldwell, G. W. de Lisle, H. M. Vordermeier, R. G. Hewinson, and D. N. Wedlock, 2011: Low oral BCG doses fail to protect cattle against an experimental challenge with Mycobacterium bovis. Tuberculosis 91, 400-405.
12. Burl, S., U. J. Adetifa, M. Cox, E. Touray, M. O. Ota, A. Marchant, H. Whittle, H. McShane, S. L. Rowland-Jones, and K. L. Flanagan, 2010: Delaying bacillus Calmette-Guerin vaccination from birth to 4 1/2 months of age reduces postvaccination Th1 and IL-17 responses but leads to comparable mycobacterial responses at 9 months of age. J. Immunol. 185, 2620-2628.
13. Cai, H., X. Tian, X. D. Hu, S. X. Li, D. H. Yu, and Y. X. Zhu, 2005: Combined DNA vaccines formulated either in DDA or in saline protect cattle from Mycobacterium bovis infection. Vaccine 23, 3887-3895.
14. Chambers, M. A., F. Rogers, R. J. Delahay, S. Lesellier, R. Ashford, D. Dalley, S. Gowtage, D. Davé, S. Palmer, J. Brewer, T. Crawshaw, R. Clifton-Hadley, S. Carter, C. Cheeseman, C. Hanks, A. Murray, K. Palphramand, S. Pietravalle, G. C. Smith, A. Tomlinson, N. J. Walker, G. J. Wilson, L. A. Corner, S. P. Rushton, M. D. Shirley, G. Gettinby, R. A. McDonald, and R. G. Hewinson, 2011: Bacillus Calmette-Guérin vaccination reduces the severity and progression of tuberculosis in badgers. Proc. Biol. Sci. 278, 1913-1920.
15. Collins, D. M., G. W. de Lisle, F. E. Aldwell, and B. M. Buddle, 2007: A new attenuated Mycobacterium bovis vaccine protects brushtail possums (Trichosurus vulpecula) against experimental tuberculosis infection. Vaccine 25, 4659-4664.
16. Corner, L. A. L., D. Murphy, E. Costello, and E. Gormley, 2009: Tuberculosis in European badgers (Meles meles) and the control of infection with bacille Calmette-Guérin vaccination. J. Wildl. Dis. 45, 1042-1047.
17. Corner, L. A., E. Costello, D. O'Meara, S. Lesellier, F. E. Aldwell, M. Singh, R. G. Hewinson, M. A. Chambers, and E. Gormley, 2010: Oral vaccination of badgers (Meles meles) with BCG and protective immunity against endobronchial challenge with Mycobacterium bovis. Vaccine 28, 6265-6272.
18. Cross, M. L., R. J. Henderson, M. R. Lambeth, B. M. Buddle, and F. E. Aldwell, 2009: Lipid-formulated BCG as an oral-bait vaccine for tuberculosis: vaccine stability, efficacy and palatability to New Zealand possums (Trichosurus vulpecula). J. Wildl. Dis. 45, 754-765.
19. de Lisle, G. W., C. G. Mackintosh, and R. G. Bengis, 2001: Mycobacterium bovis in free-living and captive wildlife, including farmed deer. Rev. Sci. Tech. 20, 86-111.
20. Desel, C., A. Dorhoi, S. Bandermann, L. Grode, B. Eisele, and S. H. Kaufmann, 2011: Recombinant BCG Delta ureC hly+ induces superior protection over parental BCG by stimulating a balanced combination of type 1 and type 17 cytokine responses. J. Infect. Dis. 204, 1573-1584.
21. Dlugovitzky, D., R. Notario, D. Martinel-Lamas, G. Fiorenza, M. Farroni, C. Bogue, C. Stanford, and J. Stanford, 2010: Immunotherapy with oral, heat-killed, Mycobacterium vaccae in patients with moderate to advanced pulmonary tuberculosis. Immunotherapy 2, 159-169.
22. Garrido, J. M., I. A. Sevilla, B. Beltrán-Beck, E. Minguijón, C. Ballesteros, R. C. Galindo, M. Boadella, K. P. Lyashchenko, B. Romero, M. V. Geijo, F. Ruiz-Fons, A. Aranaz, R. A. Juste, J. Vicente, J. de la Fuente, and C. Gortázar, 2011: Protection against tuberculosis in Eurasian wild boar vaccinated with heat-inactivated Mycobacterium bovis. PLoS ONE 6, e24905.
23. Griffin, J. M., D. H. Williams, G. E. Kelly, T. A. Clegg, I. O'Boyle, J. D. Collins, and S. J. More, 2005: The impact of badger removal on the control of tuberculosis in cattle herds in Ireland. Prev. Vet. Med. 67, 237-266.
24. Hawkridge, A., M. Hatherill, F. Little, M. A. Goetz, L. Barker, H. Mahomed, J. Sadoff, W. Hanekom, L. Geiter, and G. Hussey, 2008: Efficacy of percutaneous versus intradermal BCG in the prevention of tuberculosis in South African infants: randomised trial. BMJ 337, a2052.
25. Hoft, D. F., A. Blazevic, G. Abate, W. A. Hanekom, G. Kaplan, J. H. Soler, F. Weichold, L. Geiter, J. C. Sadoff, and M. A. Horwitz, 2008: A new recombinant bacille Calmette-Guérin vaccine safely induces significantly enhanced tuberculosis-specific immunity in human volunteers. J. Infect. Dis. 198, 1491-1501.
26. Hope, J. C., M. L. Thom, B. Villarreal-Ramos, H. M. Vordermeier, R. G. Hewinson, and C. J. Howard, 2005a: Vaccination of neonatal calves with Mycobacterium bovis BCG induces protection against intranasal challenge with virulent M. bovis. Clin. Exp. Immunol. 139, 48-56.
27. Hope, J. C., M. L. Thom, B. Villarreal-Ramos, H. M. Vordermeier, R. G. Hewinson, and C. J. Howard, 2005b: Exposure to Mycobacterium avium induces low-level protection from Mycobacterium bovis infection but compromises diagnosis of disease in cattle. Clin. Exp. Immunol. 141, 432-439.
28. Hope, J. C., M. L. Thom, M. McAulay, E. Mead, H. M. Vordermeier, D. Clifford, R. G. Hewinson, and B. Villarreal-Ramos, 2011: Identification of surrogates and correlates of protection in protective immunity against Mycobacterium bovis infection induced in neonatal calves by vaccination with M. bovis BCG Pasteur and M. bovis BCG Danish. Clin. Vaccine Immunol. 18, 373-379.
29. Infante, E., L. D. Aguilar, B. Gicquel, and R. H. Pando, 2005: Immunogenicity and protective efficacy of the Mycobacterium tuberculosis fadD26 mutant. Clin. Exp. Immunol. 141, 21-28.
30. Kamath, A. T., A. F. Rochat, D. Christensen, E. M. Agger, P. Andersen, P. H. Lambert, and C. A. Siegrist, 2009: A liposome-based mycobacterial vaccine induces potent adult and neonatal multifunctional T cells through the exquisite targeting of dendritic cells. PLoS ONE 4, e5771.
31. Khare, S., M. K. Hondalus, J. Nunes, B. R. Bloom, and L. G. Adams, 2007: Mycobacterium bovis Delta leuD auxotroph-induced protective immunity against tissue colonization, burden and distribution in cattle intranasally challenged with Mycobacterium bovis Ravenel S. Vaccine 25, 1743-1755.
32. de Klerk, L. M., A. L. Michel, R. G. Bengis, N. P. Kriek, and J. Godfroid, 2010: BCG vaccination failed to protect yearling African buffaloes (Syncerus caffer) against experimental intratonsilar challenge with Mycobacterium bovis. Vet. Immunol. Immunopathol. 137, 84-92.
33. Kupferschmidt, K., 2011: Infectious disease. Taking a new shot at a TB vaccine. Science 334, 1488-1490.
34. Lesellier, S., S. Palmer, S. Gowtage-Sequiera, R. Ashford, D. Dalley, D. Davé, U. Weyer, F. J. Salguero, A. Nunez, T. Crawshaw, L. A. Corner, R. G. Hewinson, and M. A. Chambers, 2011: Protection of Eurasian badgers (Meles meles) from tuberculosis after intra-muscular vaccination with different doses of BCG. Vaccine 29, 3782-3790.
35. Lin, P. L., J. Dietrich, E. Tan, R. M. Abalos, J. Burgos, C. Bigbee, M. Bigbee, L. Milk, H. P. Gideon, M. Rodgers, C. Cochran, K. M. Guinn, D. R. Sherman, E. Klein, C. Janssen, J. L. Flynn, and P. Andersen, 2012: The multistage vaccine H56 boosts the effects of BCG to protect cynomolgus macaques against active tuberculosis and reactivation of latent Mycobacterium tuberculosis infection. J. Clin. Invest. 122, 303-314.
36. Livingstone, P. G., T. J. Ryan, N. G. Hancox, K. B. Crews, M. A. J. Bosson, G. J. E. Knowles, and W. McCook, 2006: Regionalization: a strategy that will assist with bovine tuberculosis control and facilitate trade. Vet. Microbiol. 112, 291-301.
37. Lopez-Valencia, G., T. Renteria-Evangelista, J. de Jesús Williams, A. Licea-Navarro, A. De la Mora-Valle, and G. Medina-Basulto, 2010: Field evaluation of the protective efficacy of Mycobacterium bovis BCG vaccine against bovine tuberculosis. Res. Vet. Sci. 88, 44-49.
38. Mahomed, H., M. Kibel, T. Hawkridge, H. S. Schaaf, W. A. Hanekom, K. Iloni, D. Michaels, L. Workman, S. Verver, L. Geiter, and G. D. Hussey, 2006: The impact of a change in bacille Calmette-Guerin vaccine policy on tuberculosis incidence in children in Cape Town, South Africa. Pediatr. Infect. Dis. J. 25, 1167-1172.
39. Martin, C., A. Williams, R. Hernandez-Pando, P. J. Cardona, E. Gormley, Y. Bordat, C. Y. Soto, S. O. Clark, G. J. Hatch, D. Aguilar, V. Ausina, and B. Gicquel, 2006: The live Mycobacterium tuberculosis phoP mutant strain is more attenuated than BCG and confers protective immunity against tuberculosis in mice and guinea pigs. Vaccine 24, 3408-3419.
40. Maue, A. C., W. R. Waters, M. V. Palmer, D. L. Whipple, F. C. Minion, W. C. Brown, and D. M. Estes, 2004: CD80 and CD86, but not CD154, augment DNA vaccine-induced protection in experimental bovine tuberculosis. Vaccine 23, 769-779.
41. Maue, A. C., W. R. Waters, M. V. Palmer, B. J. Nonnecke, F. C. Minion, W. C. Brown, J. Norimine, M. R. Foote, C. F. C. Schererm, and D. M. Estes, 2007: An ESAT-6:CFP10 DNA vaccine administered in conjunction with Mycobacterium bovis BCG confers protection to cattle challenged with virulent M. bovis. Vaccine 25, 4735-4746.
42. NIH, 2011: Sex-differential health interventions in low-birth-weight infants. Available at http://clinicaltrials.gov/ct2/show/NCT00625482 (accessed April 11, 2013).
43. NIH, 2012: BCG vaccination delivered intradermally, orally and by combined routes. Available at http://clinicaltrials.gov/ct2/show/NCT00396370 (accessed April 11, 2013).
44. Nol, P., M. V. Palmer, W. R. Waters, F. E. Aldwell, B. M. Buddle, J. M. Triantis, L. M. Linke, G. E. Phillips, T. C. Thacker, J. C. Rhyan, M. R. Dunbar, and M. D. Salman, 2008: Efficacy of oral and parenteral routes of Mycobacterium bovis bacille Calmette-Guerin vaccination against experimental bovine tuberculosis in white-tailed deer (Odocoileus virginianus): a feasibility study. J. Wildl. Dis. 44, 247-259.
45. O'Brien, D. J., S. M. Schmitt, S. D. Fitzgerald, D. E. Berry, and G. J. Hickling, 2006: Managing the wildlife reservoir of Mycobacterium bovis: the Michigan, USA, experience. Vet. Microbiol. 112, 313-323.
46. Ottenhoff, T. H. M., and S. H. E. Kaufmann, 2012: Vaccines against tuberculosis: where are we and where do we need to go? PLoS Pathog. 8, e1002607.
47. Palmer, M. V., T. C. Thacker, and W. R. Waters, 2007: Vaccination of white-tailed deer (Odocoileus virginianus) with Mycobacterium bovis bacillus Calmette Guerín. Vaccine 25, 6589-6597.
48. Palmer, M. V., T. C. Thacker, and W. R. Waters, 2009: Vaccination with Mycobacterium bovis BCG strains Danish and Pasteur in white-tailed deer (Odocoileus virginianus) experimentally challenged with M. bovis. Zoonoses Public Health 56, 243-251.
49. Palphramand, K. L., S. P. Carter, J. A. Woods, G. C. Smith, N. J. Walker, and R. J. Delahay, 2012: Uptake of buried baits by badgers: implications for rabies control in Great Britain and delivery of an oral TB vaccine. Wildl. Soc. Bull. 36, 220-225.
50. Parlane, N. A., K. Grage, J. Mifune, R. J. Basaraba, D. N. Wedlock, B. H. A. Rehm, and B. M. Buddle, 2011: Vaccines displaying mycobacterial proteins on biopolyester beads stimulate cellular immunity and induce protection against tuberculosis. Clin. Vaccine Immunol. 19, 37-44.
51. Pastoret, P. P., and B. Brochier, 1996: The development and use of a vaccinia-rabies recombinant oral vaccine for the control of wildlife rabies; a link between Jenner and Pasteur. Epidemiol. Infect. 116, 235-240.
52. Roth, A. E., L. G. Stensballe, M. L. Garly, and P. Aaby, 2006: Beneficial non-targeted effects of BCG-ethical implications for the coming introduction of new TB vaccines. Tuberculosis 86, 397-403.
53. Rowland, R., and H. McShane, 2011: Tuberculosis vaccines in clinical trials. Expert Rev. Vaccines 10, 645-658.
54. Scriba, T. J., M. Tameris, N. Mansoor, E. Smit, L. van der Merwe, F. Isaacs, A. Keyser, S. Moyo, N. Brittain, A. Lawrie, S. Gelderbloem, A. Veldsman, M. Hatherill, A. Hawkridge, A. V. Hill, G. D. Hussey, H. Mahomed, H. McShane, and W. A. Hanekom, 2010: Modified vaccinia Ankara-expressing Ag85A, a novel tuberculosis vaccine, is safe in adolescents and children, and induces polyfunctional CD4+ T cells. Eur. J. Immunol. 40, 279-290.
55. Skeiky, Y. A., J. Dietrich, T. M. Lasco, K. Stagliano, V. Dheenadhayalan, M. A. Goetz, L. Cantarero, R. J. Basaraba, P. Bang, I. Kromann, J. B. McMclain, J. C. Sadoff, and P. Andersen, 2010: Non-clinical efficacy and safety of HyVac4:IC31 vaccine administered in a BCG prime-boost regimen. Vaccine 28, 1084-1093.
56. Skinner, M. A., B. M. Buddle, D. N. Wedlock, D. L. Keen, G. W. de Lisle, R. E. Tascon, J. C. Ferraz, D. B. Lowrie, P. J. Cockle, H. M. Vordermeier, and R. G. Hewinson, 2003: A DNA prime-Mycobacterium bovis BCG boost vaccination strategy in cattle induces protection against bovine tuberculosis. Infect. Immun. 71, 4901-4907.
57. Skinner, M. A., D. N. Wedlock, G. W. de Lisle, M. M. Cooke, R. E. Tascon, J. C. Ferraz, D. B. Lowrie, H. M. Vordermeier, R. G. Hewinson, and B. M. Buddle, 2005: The order of a prime-boost vaccination of neonatal calves with Mycobacterium bovis BCG and a DNA vaccine encoding mycobacterial proteins Hsp65, Hsp70 and Apa is not critical for enhancing protection against bovine tuberculosis. Infect. Immun. 73, 4441-4444.
58. Steele, J. H., 1995: Regional and country status report. In: Thoen, C. O., and J. H. Steele (eds), Mycobacterium bovis Infection in Animals and Humans, pp. 169-172. Iowa Press, Ames.
59. Sterne, J. A., L. C. Rodrigues, and I. N. Guedes, 1998: Does the efficacy of BCG decline with time since vaccination? Int. J. Tuberc. Lung Dis. 2, 200-207.
60. Sun, R., Y. A. Skeiky, A. Izzo, V. Dheenadhayalan, Z. Imam, E. Penn, K. Stagliano, S. Haddock, S. Mueller, J. Fulkerson, C. Scanga, A. Grover, S. C. Derrick, S. Morris, D. M. Hone, M. A. Horwitz, S. H. Kaufmann, and J. C. Sadoff, 2009: Novel recombinant BCG expressing perfringolysin O and the over-expression of key immunodominant antigens; pre-clinical characterization, safety and protection against challenge with Mycobacterium tuberculosis. Vaccine 27, 4412-4423.
61. Thom, M. L., M. McAulay, H. M. Vordermeier, D. Clifford, R. G. Hewinson, B. Villarreal-Ramos, and J. C. Hope, 2012: Duration of immunity against Mycobacterium bovis following neonatal vaccination with bacillus Calmette-Guérin Danish: significant protection against infection at 12, but not 24, months. Clin. Vaccine Immunol. 19, 1254-1260.
62. Tompkins, D. M., D. S. L. Ramsey, M. L. Cross, F. E. Aldwell, G. W. de Lisle, and B. M. Buddle, 2009: Oral vaccination reduces the incidence of bovine tuberculosis in a free-living wildlife species. Proc. Biol. Sci. 276, 2987-2995.
63. Van Dissel, J. T., S. M. Arend, C. Prins, P. Bang, P. N. Tingskov, K. Lingnau, J. Nouta, M. R. Klein, I. Rosenkrands, T. H. Ottenhoff, I. Kromann, T. M. Doherty, and P. Andersen, 2010: Ag85B-ESAT-6 adjuvanted with IC31 promotes strong and long-lived Mycobacterium tuberculosis specific T cell responses in naive human volunteers. Vaccine 28, 35713581.
64. Vilaplana, C., O. Gil, N. Caceres, S. Pinto, J. Diaz, and P. J. Cardona, 2011: Prophylactic effect of a therapeutic vaccine against TB based on fragments of Mycobacterium tuberculosis. PLoS ONE 6, e20404.
65. Von Eschen, K., R. Morrison, M. Braun, O. Ofori-Anyinam, E. De Kock, P. Pavithran, M. Koutsoukos, P. Moris, D. Cain, M. C. Dubois, J. Cohen, and W. R. Ballou, 2009: The candidate tuberculosis vaccine Mtb72F/AS02A: tolerability and immunogenicity in humans. Hum. Vaccin. 5, 475-482.
66. Vordermeier, H. M., B. Villaraeal-Ramos, P. J. Cockle, M. McAulay, S. G. Rhodes, T. Thacker, S. C. Gilbert, H. McShane, A. V. S. Hill, Z. Xing, and R. G. Hewinson, 2009: Viral booster vaccines improve Mycobacterium bovis BCG-induced protection against bovine tuberculosis. Infect. Immun. 77, 3364-3373.
67. Vordermeier, M., S. V. Gordon, and R. G. Hewinson, 2011: Mycobacterium bovis antigens for the differential diagnosis of vaccinated and infected cattle. Vet. Microbiol. 151, 8-13.
68. Waters, W. R., M. V. Palmer, B. J. Nonnecke, T. C. Thacker, C. F. Capinos Scherer, D. M. Estes, W. J. Jacobs Jr, A. Glatman-Freedman, and M. H. Larsen, 2007: Failure of a Mycobacterium tuberculosis {increment}RD1{increment}panCD double deletion mutant in a neonatal calf aerosol M. bovis challenge model: comparisons to responses elecited by M. bovis bacille Calmette Guérin. Vaccine 25, 7832-7840.
69. Waters, W. R., M. V. Palmer, B. J. Nonnecke, T. C. Thacker, C. F. Capinos Scherer, D. M. Estes, R. G. Hewinson, H. M. Vordermeier, S. W. Barnes, G. C. Federe, J. R. Walker, R. J. Glynne, T. Hsu, B. Weinrick, K. Biermann, M. H. Larsen, and W. R.Jacobs Jr, 2009: Efficacy and immunogenicity of Mycobacterium bovis {increment}RD1 against aerosol M. bovis infection in neonatal calves. Vaccine 27, 1201-1209.
70. Waters, W. R., M. V. Palmer, B. M. Buddle, and H. M. Vordermeier, 2012: Bovine tuberculosis vaccine research: historical perspectives and recent advances. Vaccine 30, 2611-2622.
71. Wedlock, D. N., M. A. Skinner, N. A. Parlane, H. M. Vordermeier, R. G. Hewinson, G. W. deLisle, and B. M. Buddle, 2003: Vaccination of cattle with DNA vaccines encoding the mycobacterial antigens MPB70 and MPB83: protein boosting induces antibody and does not enhance vaccine efficacy. Tuberculosis 83, 339-349.
72. Wedlock, D. N., M. Denis, M. A. Skinner, J. Koach, G. W. de Lisle, H. M. Vordermeier, R. G. Hewinson, S. van Drunen Littel-van den Hurk, L. A. Babiuk, R. Hecker, and B. M. Buddle, 2005: Vaccination of cattle with a CpG oligodeoxynucleotide-formulated mycobacterial protein vaccine and Mycobacterium bovis BCG induces levels of protection against bovine tuberculosis superior to vaccination with BCG alone. Infect. Immun. 73, 3540-3546.
73. Wedlock, D. N., M. Denis, H. M. Vordermeier, R. G. Hewinson, and B. M. Buddle, 2007: Vaccination of cattle with Danish and Pasteur strains of Mycobacterium bovis BCG induce different levels of IFNgamma post-vaccination, but induce similar levels of protection against bovine tuberculosis. Vet. Immunol. Immunopathol. 118, 50-58.
74. Wedlock, D. N., M. Denis, G. F. Painter, G. D. Ainge, H. M. Vordermeie, R. G. Hewinson, and B. M. Buddle, 2008: Enhanced protection against bovine tuberculosis after coadministration Mycobacterium bovis BCG and a mycobacterial protein vaccine-adjuvant combination, but not after coadministration of adjuvant alone. Clin. Vaccine Immunol. 15, 765-772.
75. Wedlock, D. N., F. E. Aldwell, G. W. de Lisle, H. M. Vordermeier, R. G. Hewinson, and B. M. Buddle, 2011: Protection against bovine tuberculosis induced by oral vaccination of cattle with Mycobacterium bovis BCG is not enhanced by co-administration of mycobacterial protein vaccines. Vet. Immunol. Immunopathol. 144, 220-227.
76. Whelan, A. O., D. Clifford, B. Upadhyay, E. L. Breadon, J. McNair, R. G. Hewinson, and H. M. Vordermeier, 2011: Development of a skin test for bovine tuberculosis for differentiating infected from vaccinated animals. J. Clin. Microbiol. 48, 3176-3181.
77. WHO, 2004: BCG vaccine. WHO position paper. Wkly Epidemiol. Rec. 79, 27-38.
78. WHO, 2012: Global Tuberculosis Report 2012, World Health Organisation.